Traws Pharma, Inc.
TRAW
$1.88
$0.021.08%
NASDAQ
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 13.08M | 15.94M | 21.34M | 5.41M | 16.89M |
Total Receivables | 1.32M | 1.65M | 1.77M | 2.12M | 18.00K |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | 49.00K | 149.00K | 156.00K | 163.00K | 183.00K |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | 917.00K | 1.12M | 1.69M | 1.23M | 1.58M |
Total Current Assets | 15.37M | 18.86M | 24.95M | 8.92M | 18.67M |
|
|||||
Total Current Assets | 15.37M | 18.86M | 24.95M | 8.92M | 18.67M |
Net Property, Plant & Equipment | 8.00K | 9.00K | 10.00K | 12.00K | 14.00K |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 244.00K | 198.00K | 1.00K | 1.00K | 1.00K |
Total Assets | 15.62M | 19.06M | 24.96M | 8.94M | 18.69M |
|
|||||
Total Accounts Payable | 4.76M | 7.66M | 8.19M | 5.47M | 6.17M |
Total Accrued Expenses | 2.59M | 2.52M | 3.12M | 2.65M | 3.51M |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Liabilities | -- | 226.00K | 226.00K | 226.00K | 227.00K |
Total Other Current Liabilities | -- | 226.00K | 226.00K | 226.00K | 227.00K |
Total Current Liabilities | 7.35M | 10.40M | 11.53M | 8.35M | 9.91M |
|
|||||
Total Current Liabilities | 7.35M | 10.40M | 11.53M | 8.35M | 9.91M |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | 8.00K | 2.66M | 45.06M | 2.62M | 2.68M |
Total Liabilities | 7.36M | 13.06M | 56.59M | 10.97M | 12.59M |
|
|||||
Common Stock & APIC | 636.83M | 633.68M | 617.57M | 617.23M | 505.27M |
Retained Earnings | -628.58M | -627.66M | -649.15M | -619.23M | -610.76M |
Treasury Stock & Other | 9.00K | -19.00K | -42.00K | -33.00K | -33.00K |
Total Common Equity | 8.26M | 6.00M | -31.63M | -2.03M | -105.52M |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | 111.62M |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | 111.62M |
|
|||||
Total Common Equity | 8.26M | 6.00M | -31.63M | -2.03M | -105.52M |
Total Preferred Equity | -- | -- | -- | -- | 111.62M |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 8.26M | 6.00M | -31.63M | -2.03M | 6.10M |
|